Deucravacitinib by Bristol-Myers Squibb can help with psoriasis, psoriatic arthritis, Crohn’s disease, ulcerative colitis, and systemic lupus erythematosus.
Novo Nordisk will offer a very patient-friendly weekly version of insulin.
What new drugs for hair loss are being developed by the pharmaceutical industry?
Roflumilast will cure plaque psoriasis in half of patients.
Ruxolitinib cream will help most patients treat nonsegmental vitiligo.
Ublituximab is the third anti-CD20 therapy for multiple sclerosis and a worthy rival to Ocrevus and Kesimpta.
Teprotumumab by Horizon Therapeutics can really help with proptosis and diplopia in Graves’ disease and beyond.